Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (94 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.222/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.222 |
| Version | 20220910 |
| Status | active |
| Date | 2022-09-10T01:02:30-04:00 |
| Name | HighEmeticRiskIntravenousAntineoplasticAgent |
| Title | High Emetic Risk Intravenous Antineoplastic Agent |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of high emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a high emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.1444.3.222",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2023-09-26"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2022-09-10"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.222",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.3.222"
}
],
"version" : "20220910",
"name" : "HighEmeticRiskIntravenousAntineoplasticAgent",
"title" : "High Emetic Risk Intravenous Antineoplastic Agent",
"status" : "active",
"experimental" : false,
"date" : "2022-09-10T01:02:30-04:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of high emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a high emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1731338",
"display" : "dacarbazine 200 MG Injection"
},
{
"code" : "1731340",
"display" : "dacarbazine 100 MG Injection"
},
{
"code" : "1736854",
"display" : "cisplatin 50 MG Injection"
},
{
"code" : "239180",
"display" : "streptozocin 1000 MG Injection"
},
{
"code" : "2605054",
"display" : "carmustine 300 MG Injection"
},
{
"code" : "2605056",
"display" : "carmustine 50 MG Injection"
},
{
"code" : "309012",
"display" : "carmustine 100 MG Injection"
},
{
"code" : "309311",
"display" : "cisplatin 1 MG/ML Injectable Solution"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:91751771-b285-4969-93ea-e160ff449db7",
"timestamp" : "2024-12-10T10:12:01-05:00",
"total" : 8,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1731338",
"display" : "dacarbazine 200 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1731340",
"display" : "dacarbazine 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1736854",
"display" : "cisplatin 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "239180",
"display" : "streptozocin 1000 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2605054",
"display" : "carmustine 300 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2605056",
"display" : "carmustine 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "309012",
"display" : "carmustine 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "309311",
"display" : "cisplatin 1 MG/ML Injectable Solution"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR